Pfizer, Allergan close to $150 billion merger: reports

SHARE Pfizer, Allergan close to $150 billion merger: reports

Pfizer Inc. and Botox-maker Allergan Plc could announce a $150 billion merger plan as soon as Monday, according to reports.

The companies’ boards were expected to vote Sunday on a plan that would create a pharmaceutical giant and possibly shift its headquarters to Europe for tax savings, the New York Times and Wall Street Journal reported Sunday.

Pfizer completed its $15 billion deal for Hospira, the Lake Forest maker of injectable drugs, in September.

A merger could enable Viagra maker Pfizer, the world’s second-biggest drugmaker by revenue, to surpass Switzerland’s Novartis AG and regain the industry’s top spot. It would also add Allergan’s brand-name medicines for eye conditions, infections and heart disease to Pfizer’s extensive portfolio of vaccines and drugs for cancer, pain, erectile dysfunction and other conditions.

The Latest
York senior Kelly Watson was the last player off the field on Friday in Elmhurst. There were interviews to do and congratulations to receive.
Grandal’s poor season went hand in hand with the White Sox’ bad year.
The boy was riding with his mother and three other children about 8:40 p.m. in the 4400 block of West Marquette Road when he was shot in the head, police said.